Thomas Schall
Director/Board Member bij IMMUNEERING CORPORATION
Vermogen: 8 381 $ op 31-03-2024
Actieve functies van Thomas Schall
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| IMMUNEERING CORPORATION | Director/Board Member | 12-03-2024 | - |
Loopbaan van Thomas Schall
Eerdere bekende functies van Thomas Schall
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| CHEMOCENTRYX, INC. | Director/Board Member | 01-10-1997 | 01-04-2012 |
| Chief Executive Officer | 01-10-1997 | 20-10-2022 | |
| Chairman | 01-04-2012 | 20-10-2022 | |
| Founder | 01-10-1997 | 20-10-2022 | |
| President | 01-10-1997 | 20-10-2022 | |
| DNAX Research, Inc. | Corporate Officer/Principal | 01-12-1993 | 01-01-1997 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Chief Tech/Sci/R&D Officer | - | - |
Opleiding van Thomas Schall
| Stanford University | Doctorate Degree |
| Northern Illinois University | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 7 |
Operationeel
| Director/Board Member | 2 |
| Chief Executive Officer | 1 |
| Chairman | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| IMMUNEERING CORPORATION | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
ChemoCentryx, Inc.
 ChemoCentryx, Inc. Pharmaceuticals: MajorHealth Technology ChemoCentryx, Inc. is a biopharmaceutical company, which engages in the development and commercialization of medicines. It focuses on inflammatory disorders, autoimmune diseases, and cancer. Its drug candidates such as Avacopan and CCX140, selectively blocks a specific chemoattractant receptor, leaving the rest of the immune system intact. The company was founded by Thomas J. Schall in 1997 and is headquartered in San Carlos, CA. | Health Technology |
| DNAX Research, Inc. |
- Beurs
- Insiders
- Thomas Schall
- Ervaring
